Page last updated: 2024-11-03

risperidone and Familial Hyperpotassemia and Hypertension

risperidone has been researched along with Familial Hyperpotassemia and Hypertension in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"Probably pseudohypoaldosteronism was a coincidental finding in this girl with a CDK13 mutation, but because only limited information is known about CDK13-related disorders, further investigation could be more informative to clarify this presentation."2.61One-month-old girl presenting with pseudohypoaldosteronism leading to the diagnosis of CDK13-related disorder: a case report and review of the literature. ( Ayman, A; Kremer, AK; van den Akker, M; Yakubov, R, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yakubov, R1
Ayman, A1
Kremer, AK1
van den Akker, M1

Reviews

1 review available for risperidone and Familial Hyperpotassemia and Hypertension

ArticleYear
One-month-old girl presenting with pseudohypoaldosteronism leading to the diagnosis of CDK13-related disorder: a case report and review of the literature.
    Journal of medical case reports, 2019, Dec-29, Volume: 13, Issue:1

    Topics: CDC2 Protein Kinase; Chelating Agents; DNA Mutational Analysis; Female; Humans; Infant; Intellectual

2019